Frederick; Brian Troy

Patent Applications and Registrations

Patent applications and USPTO patent grants for Frederick; Brian Troy.The latest application filed is for "peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases".

Company Profile

21.14.26

Frederick; Brian Troy - Ben Lomand CA
Frederick; Brian Troy - Ben Lomond CA
Frederick; Brian Troy - Newark CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Peptide Inhibitors Of Interleukin-23 Receptor And Their Use To Treat Inflammatory Diseases App 20220251142 - BHANDARI; Ashok ; et al.	2022-08-11
Peptide Inhibitors Of Interleukin-23 Receptor And Their Use To Treat Inflammatory Diseases App 20220041658 - Bhandari; Ashok ; et al.	2022-02-10
NOVEL a4B7 THIOETHER PEPTIDE DIMER ANTAGONISTS App 20210371466 - Bhandari; Ashok ; et al.	2021-12-02
Oral Peptide Inhibitors Of Interleukin-23 Receptor And Their Use To Treat Inflammatory Bowel Diseases App 20210363185 - BHANDARI; Ashok ; et al.	2021-11-25
Peptide Inhibitors Of Interleukin-23 Receptor And Their Use To Treat Inflammatory Diseases App 20210261622 - Sun; Chengzao ; et al.	2021-08-26
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases Grant 11,041,000 - Bhandari , et al. June 22, 2	2021-06-22
Analogues Of Hepcidin Mimetics With Improved In Vivo Half Lifes App 20210147483 - Bourne; Gregory Thomas ; et al.	2021-05-20
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases Grant 10,941,183 - Bhandari , et al. March 9, 2	2021-03-09
Peptide Inhibitors Of Interleukin-23 Receptor And Their Use To Treat Inflammatory Diseases App 20210009638 - Bhandari; Ashok ; et al.	2021-01-14
Conjugated Hepcidin Mimetics App 20200361992 - BOURNE; Gregory Thomas ; et al.	2020-11-19
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases Grant 10,787,490 - Bhandari , et al. September 29, 2	2020-09-29
Opioid agonist peptides and uses thereof Grant 10,729,676 - Anandan , et al.	2020-08-04
NOVEL a4B7 THIOETHER PEPTIDE DIMER ANTAGONISTS App 20200239523 - Bhandari; Ashok ; et al.	2020-07-30
.alpha.4.beta.7 thioether peptide dimer antagonists Grant 10,626,146 - Bhandari , et al.	2020-04-21
Peptide Inhibitors Of Interleukin-23 Receptor And Their Use To Treat Inflammatory Diseases App 20200040037 - Bhandari; Ashok ; et al.	2020-02-06
Hepcidin And Mini-hepcidin Analogues And Uses Therof App 20200017566 - BOURNE; Gregory Thomas ; et al.	2020-01-16
Hepcidin analogues and uses thereof Grant 10,501,515 - Smythe , et al. Dec	2019-12-10
Oral Peptide Inhibitors Of Interleukin-23 Receptor And Their Use To Treat Inflammatory Bowel Diseases App 20190337983 - Bhandari; Ashok ; et al.	2019-11-07
Hepcidin analogues and uses thereof Grant 10,442,846 - Smythe , et al. Oc	2019-10-15
Peptide Inhibitors Of Interleukin-23 Receptor And Their Use To Treat Inflammatory Diseases App 20190300590 - BHANDARI; Ashok ; et al.	2019-10-03
Opioid Agonist Peptides And Uses Thereof App 20190231746 - Anandan; Sampath-Kumar ; et al.	2019-08-01
Hepcidin Analogues And Uses Therof App 20190185536 - SMYTHE; Mark Leslie ; et al.	2019-06-20
Hepcidin Analogues And Uses Thereof App 20190185535 - Smythe; Mark Leslie ; et al.	2019-06-20
Opioid agonist peptides and uses thereof Grant 10,278,957 - Anandan , et al.	2019-05-07
Opioid Agonist Peptides And Uses Thereof App 20190076400 - Anandan; Sampath Kumar ; et al.	2019-03-14
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases Grant 10,196,424 - Bourne , et al. Fe	2019-02-05
NOVEL a4B7 THIOETHER PEPTIDE DIMER ANTAGONISTS App 20190016756 - Bhandari; Ashok ; et al.	2019-01-17
Analogues Of Hepcidin Mimetics With Improved In Vivo Half Lives App 20190002503 - Bourne; Gregory Thomas ; et al.	2019-01-03
.alpha.4.beta.7 thioether peptide dimer antagonists Grant 10,059,744 - Bhandari , et al. August 28, 2	2018-08-28
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases Grant 10,035,824 - Bhandari , et al. July 31, 2	2018-07-31
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases Grant 10,023,614 - Bhandari , et al. July 17, 2	2018-07-17
NOVEL a4B7 THIOETHER PEPTIDE DIMER ANTAGONISTS App 20180099995 - Bhandari; Ashok ; et al.	2018-04-12
Oral Peptide Inhibitors Of Interleukin-23 Receptor And Their Use To Treat Inflammatory Bowel Diseases App 20180079783 - Bhandari; Ashok ; et al.	2018-03-22
Oral Peptide Inhibitors Of Interleukin-23 Receptor And Their Use To Treat Inflammatory Bowel Diseases App 20180079782 - Bhandari; Ashok ; et al.	2018-03-22
Oral Peptide Inhibitors Of Interleukin-23 Receptor And Their Use To Treat Inflammatory Bowel Diseases App 20180022778 - Bourne; Gregory ; et al.	2018-01-25
Hepcidin And Mini-hepcidin Analogues And Uses Thereof App 20170313754 - BOURNE; Gregory Thomas ; et al.	2017-11-02
a4B7 integrin thioether peptide antagonists Grant 9,714,270 - Bhandari , et al. July 25, 2	2017-07-25
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases Grant 9,624,268 - Bourne , et al. April 18, 2	2017-04-18
Oral Peptide Inhibitors Of Interleukin-23 Receptor And Their Use To Treat Inflammatory Bowel Diseases App 20160145306 - Bourne; Gregory Thomas ; et al.	2016-05-26
a4B7 INTEGRIN THIOETHER PEPTIDE ANTAGONISTS App 20160031944 - Bhandari; Ashok ; et al.	2016-02-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.